The drug enhances outcomes in a high-risk patient population with a significant unmet need. Tirzepatide significantly improved kidney function and cardiovascular outcomes in patients with obesity and heart failure with preserved ejection fraction…
New Weight Loss & Heart Drug Shows Significant Benefits in Major Trial of Obese Patients
